Patents Assigned to KAHR MEDICAL(2005) LTD
  • Compositions and methods for treatment of hematological malignancies
    Patent number: 9388230
    Abstract: Use of a chimeric protein selected from the group consisting of CTLA4-FasL and CD40-FasL proteins for treatment of lymphoma and/or a multiple myeloma and/or a leukemia as described herein, and pharmaceutical compositions and methods of treatment thereof.
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: July 12, 2016
    Assignees: KAHR MEDICAL(2005) LTD, HADASIT MEDICAL RESEARCH SERVICE AND DEVELOPMENT CO. LTD.
    Inventor: Michal Dranitzki Elhalel